The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07351435

Enrollment

1200

Registered

2026-01-20

Start date

2026-02-01

Completion date

2033-06-30

Last updated

2026-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure, ARDS (Acute Respiratory Distress Syndrome), Cardiac Arrest (CA), Cardiogenic Shock, Drepanocytosis and Thoracic Syndrome, Intoxication, Ischemic or Valvular Heart Failure, Malignant Arrhythmias, Postcardiotomy Heart Failure, Pulmonary Thromboembolisms, Sepsis

Keywords

acute heart failure, respiratory insufficiency

Brief summary

The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing VV, VA or VAV ECMO implantation in the French West Indies and Guiana. All patients undergoing ECMO implantation will be prospectively registered.

Detailed description

In the Caribbean region, access to advanced cardiac interventions faces difficulties owing to unequal distribution of health care resources, medical shortages and distance between health care centers in various islands. At the University Hospital of Martinique (UHM) in Fort de France, a mobile ECMO team is available 24h a day, 7 days a week, for cardiopulmonary mechanical support in the French Overseas Territories and neighboring islands. Implantation of veno-venous or veno-arterial (VV or VA) ECMO can be performed at the UHM or at remote hospitals. Some patients on VA-ECMO are transfered by airflight to the UHM and/or to French mainland whenever cardiac transplantation is indicated. Since 2010, the ECMO-UHM database is a prospective event-driven registry housed and updated by the HeartTeam (perfusionnists, emergency and ICU physicians, cardiac surgeons, cardiothoracic anesthesiologists, cardiologists).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

No minimum to 90 Years

Healthy volunteers

Inclusion criteria

* All consecutive patients implanted with a veno-venous extracorporeal membrane oxygenation device or extracorporeal membrane oxygenation device by the HeartTeam from the University Hospital of Martinique (UHM) from January 2010

Exclusion criteria

* Patients with incomplete data (primary endpoint and less than 80% secondary study outcomes)

Design outcomes

Primary

Measure	Time frame	Description
Mortality at 30 days	from canula implantation to 30 days afterwards	Number of deceased participants as assessed at 30 days after ECMO implantation

Secondary

Measure	Time frame	Description
Number of participants with major adverse events	From canula implantation to up to 6 months after ECMO implantation	Major Adverse events (AE; numbers and rates) as assessed by the consensus statement of the mechanical circulatory support academic research consortium

Contacts

CONTACTMarc LICKER, MD

marc.licker@unige.ch+41796234488

CONTACTJeremy MAZILE, BC perfusionnist

jermy.bazile@chu-martinique.fr

PRINCIPAL_INVESTIGATORMarc LICKER, BC

CHU Martinique

Outcome results